July 7 (Reuters) - BioCardia Inc:
* BIOCARDIA INC - SUBMITTED DETAILED RESPONSE FDA RELATED TO INVESTIGATIONAL NEW DRUG APPLICATION FOR BCDA-03
* BIOCARDIA INC - RECEIVED CONFIRMATION THAT FDA RECEIVED SUBMISSION ON JULY 2, 2020. Source: bit.ly/2O1ynpL Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.